Jiang Xi Sanxin Medtec Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001ZJ1
CNY
9.15
-0.01 (-0.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
396.55
357.44
414.61
392.48
352.40
328.63
367.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
396.55
357.44
414.61
392.48
352.40
328.63
367.51
Raw Material Cost
269.44
246.19
276.13
266.58
237.79
224.06
243.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.06
0.44
0.11
1.02
1.15
0.84
0.73
Selling and Distribution Expenses
41.87
35.58
49.40
41.18
38.22
37.82
41.05
Other Expenses
1.42
1.41
1.75
1.38
1.39
1.02
1.54
Total Expenditure (Excl Depreciation)
326.54
296.32
343.15
322.60
291.06
272.92
301.05
Operating Profit (PBDIT) excl Other Income
70
61.1
71.5
69.9
61.3
55.7
66.5
Other Income
7.93
4.99
19.04
3.94
2.85
7.70
13.20
Operating Profit (PBDIT)
107.08
95.50
106.21
100.09
83.10
83.02
99.73
Interest
1.06
0.44
0.11
1.02
1.15
0.84
0.73
Exceptional Items
2.10
1.10
-9.79
2.35
3.12
2.16
1.30
Gross Profit (PBDT)
127.11
111.25
138.48
125.89
114.61
104.57
123.69
Depreciation
29.48
29.48
26.34
26.34
19.20
19.20
19.60
Profit Before Tax
78.64
66.69
69.97
75.07
65.87
65.14
80.69
Tax
10.83
7.31
5.62
7.11
8.16
7.47
9.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
61.39
53.73
59.49
61.67
52.63
53.62
65.22
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
61.39
53.73
59.49
61.67
52.63
53.62
65.22
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
6.42
5.65
4.87
6.30
5.08
4.05
6.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
67.81
59.38
64.36
67.96
57.71
57.67
71.23
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,346.38
1,383.07
1,324.07
1,248.44
1,234.78
1,257.72
1,246.43
Earnings per share (EPS)
0.12
0.1
0.11
0.12
0.1
0.1
0.13
Diluted Earnings per share
0.12
0.1
0.11
0.12
0.1
0.1
0.13
Operating Profit Margin (Excl OI)
17.57%
17.07%
14.67%
17.79%
17.32%
17.08%
18.21%
Gross Profit Margin
27.26%
26.9%
23.23%
25.84%
24.14%
25.66%
27.29%
PAT Margin
15.48%
15.03%
14.35%
15.71%
14.93%
16.32%
17.75%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 12.54% vs 14.94% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 17.50% vs 18.00% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 23.69% vs 15.40% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is 0.00% vs -26.67% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Jiang Xi Sanxin Medtec Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
396.55
0
396.55
Other Operating Income
0.00
0.00
0.00
Total Operating income
396.55
0
396.55
Raw Material Cost
269.44
0
269.44
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.06
0
1.06
Selling and Distribution Expenses
41.87
0
41.87
Other Expenses
1.42
0.00
1.42
Total Expenditure (Excl Depreciation)
326.54
0
326.54
Operating Profit (PBDIT) excl Other Income
70.01
0.00
70.01
Other Income
7.93
0
7.93
Operating Profit (PBDIT)
107.08
0
107.08
Interest
1.06
0
1.06
Exceptional Items
2.10
0
2.10
Gross Profit (PBDT)
127.11
0
127.11
Depreciation
29.48
0
29.48
Profit Before Tax
78.64
0
78.64
Tax
10.83
0
10.83
Provisions and contingencies
0
0
0.00
Profit After Tax
61.39
0
61.39
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
61.39
0
61.39
Share in Profit of Associates
0
0
0.00
Minority Interest
6.42
0
6.42
Other related items
0.00
0.00
0.00
Consolidated Net Profit
67.81
0
67.81
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,346.38
0
1,346.38
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
17.57%
0%
0.00
17.57%
Gross Profit Margin
27.26%
0%
0.00
27.26%
PAT Margin
15.48%
0%
0.00
15.48%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 39.66 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 10.97% vs -13.80% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.54% vs 14.94% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.78 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 14.14% vs -7.76% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 17.50% vs 18.00% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.92 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 9.61% vs 3.78% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 23.69% vs 15.40% in Jun 2024

Quarterly - Interest
Interest 0.11 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 175.00% vs 300.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 0.00% vs -26.67% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.57%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024